RESUMO
The mortality rate in susceptible populations of horses during an epizootic of African horse sickness (AHS) may be in excess of 90%. Rapid and reliable assays are therefore essential for the confirmation of clinical diagnoses and to enable control strategies to be implemented without undue delay. One of the major objectives of a recent European Union funded project was the validation of newly developed diagnostic assays which are rapid, sensitive, highly reproducible and inexpensive, for the detection of African horse sickness virus (AHSV) antigens and antibodies. The Laboratorio de Sanidad y Produccion Animal (LSPA) in Algete, Spain was charged with the responsibility of co-ordinating and supplying samples of viruses and antisera to the participating laboratories in Spain, France and the United Kingdom. The panels comprised 76 antigen samples for assay by indirect sandwich ELISAs and 53 serum samples for antibody detection by either indirect or competitive ELISAs. Results generated by ELISA for each laboratory were analysed in LSPA in terms of their relative sensitivities and specificities. There was a good agreement between the ELISAs used for either antigen or antibody detection. The participating groups agreed that any field sample giving a doubtful result would always be retested by ELISA and an alternative assay.
Assuntos
Vírus da Doença Equina Africana/imunologia , Doença Equina Africana/diagnóstico , Anticorpos Antivirais/sangue , Antígenos Virais/análise , Ensaio de Imunoadsorção Enzimática/veterinária , Doença Equina Africana/imunologia , Animais , Bovinos , Ensaio de Imunoadsorção Enzimática/métodos , Cobaias , Cavalos , Soros Imunes/imunologia , Camundongos , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
The major core protein, VP7, of African horsesickness virus serotype 4 (AHSV-4), the aetiological agent of a recent outbreak of the disease in southern Europe, was expressed in insect cells infected with a recombinant baculovirus containing a cloned copy of the relevant AHSV gene (S7). Analyses of its biochemical and antigenic properties confirmed the authenticity of the protein expressed. The high-level expression of VP7 under the control of the strong polyhedrin promoter of Autographa californica nuclear polyhedrosis virus induced disc-shaped crystals in infected insect cells. This enabled us to purify the protein by a one-step ultracentrifugation procedure and to utilize it for the detection of antibodies raised in horses to various serotypes of AHSV. A serological relationship between AHSV and two other orbiviruses, bluetongue virus and epizootic haemorrhagic disease virus, was also demonstrated.
Assuntos
Vírus da Doença Equina Africana/imunologia , Doença Equina Africana/diagnóstico , Antígenos Virais/biossíntese , Proteínas do Core Viral/biossíntese , Vírus da Doença Equina Africana/genética , Animais , Antígenos Virais/imunologia , Baculoviridae/genética , Sequência de Bases , Células Cultivadas , Reações Cruzadas , Epitopos/imunologia , Vetores Genéticos , Dados de Sequência Molecular , Proteínas Recombinantes/biossíntese , Recombinação Genética , Reoviridae/imunologia , Sorotipagem , Proteínas do Core Viral/genética , Proteínas do Core Viral/imunologiaRESUMO
Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to develop a humoral immune response detectable by immunoblotting. The earliest serological markers corresponded mainly to VP5, VP6, and NS2 and to a lesser extent to VP3, NS1, and NS3. Neutralizing antibodies to VP2 were not detected by immunoblotting, suggesting that they are mostly conformation dependent. VP7-specific antibodies were detected later in infection. These results make NS2 and VP6 the most attractive candidates for the rapid diagnosis of the infection.
Assuntos
Vírus da Doença Equina Africana/imunologia , Doença Equina Africana/imunologia , Anticorpos Antivirais/sangue , Antígenos Virais , Proteínas do Capsídeo , Animais , Western Blotting , Capsídeo/imunologia , Vacinação , Proteínas Virais/imunologia , Vacinas Virais/imunologiaRESUMO
African horsesickness virus serotype 4 (AHSV-4) outer capsid protein VP2, or VP2 and VP5 plus inner capsid protein VP7, derived from single or dual recombinant baculovirus expression vectors were used in different combinations to immunize horses. When the proteins were purified by affinity chromatography, the combination of all three proteins induced low levels of neutralizing antibodies and conferred protection against virulent virus challenge. However, purified VP2 or VP2 and VP5 in the absence of VP7 failed to induce neutralizing antibodies and protection. Immunization with non-purified proteins enhanced the titres of neutralizing antibodies. Again, the combination of the three proteins was able to confer total protection to immunized horses, which showed absence of viraemia. The antigenicity of recombinant VP2 was analysed with a collection of 30 MAbs. Both purified and unpurified recombinant VP2 proteins showed different antigenic patterns in comparison to that of VP2 on virions. An immunization experiment with four more horses confirmed these results. The vaccine described here would not only prevent the disease, but would drastically reduce the propagation of the virus by vectors.